Clinical trialNAActive not recruiting
A RCT of Low MBO Drainage Strategies
A Randomized Controlled Trial of Malignancy Low Biliary Tract Obstruction Drainage Strategies
- Outcome
- Ongoing
- Phase
- NA
- Status
- Active not recruiting
- Study type
- Interventional
- Start
- 25 January 2024
- Expected end
- August 2026
- Enrollment
- 40 participants
- Sites
- 1
- Primary outcomes
- stent patency time
- Sponsor
- Other
- Results posted
- No
- Last update
- 5 September 2025
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The purpose of this study is to evaluate the efficacy and safety of EUS-BD compared with ERCP-BD in low biliary obstruction caused by periampullary cancer, pancreatic cancer or low bile duct cancer. This is a single center, prospective, randomized-controlled study. The primary endpoint of this study is stent patency time, and secondary endpoints include technical success rate, clinical success rate, operation time, operation related complications rate, reintervention rate, stent patency rate at 6 months, and 1-year postoperative survival rate.